Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients.
about
Clinical methods for the evaluation of endothelial function-- a focus on resistance arteries.Vascular endothelial-specific dimethylarginine dimethylaminohydrolase-1-deficient mice reveal that vascular endothelium plays an important role in removing asymmetric dimethylarginine.Mechanisms of nitric oxide synthase uncoupling in endotoxin-induced acute lung injury: role of asymmetric dimethylarginine.IGF-1 and ADMA levels are inversely correlated in nondiabetic ankylosing spondylitis patients undergoing anti-TNF-alpha therapyThe Role of Obesity in Preeclampsia.Endothelial dysfunction: its role in hypertensive coronary disease.Effects of coenzyme Q10 and α-lipoic acid supplementation in fructose fed ratsAsymmetric dimethylarginine (ADMA): the silent transition from an 'uraemic toxin' to a global cardiovascular risk molecule.Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.Endothelial function and arterial stiffness in uncomplicated type 1 diabetes and healthy controls and the impact of insulin on these parameters during an euglycemic clamp.Relation of asymmetric dimethylarginine levels to macrovascular disease and inflammation markers in type 2 diabetic patientsEffects of propolis, caffeic acid phenethyl ester, and pollen on renal injury in hypertensive rat: An experimental and theoretical approach.Effect of enzyme replacement therapy on serum asymmetric dimethylarginine levels, coronary flow reserve and left ventricular hypertrophy in patients with Fabry disease.Nitric oxide and asymmetric dimethyl arginine (ADMA) levels in an experimental hydronephrotic kidney caused by unilateral partial ureteral obstruction.Comment on: Tessari et al. Roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo. Diabetes 2013;62:2699-2708.Increased levels of asymmetric dimethylarginine and C-reactive protein are associated with impaired vascular reactivity in essential hypertension.Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated Type 2 diabetic patients.Reduced nitric oxide bioavailability contributes to skeletal muscle microvessel rarefaction in the metabolic syndrome.Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension.Decreased coronary flow reserve in haemodialysis patients.The role of asymmetric dimethylarginine (ADMA) and leptin in hypertensive patients.Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction.
P2860
Q33242082-739D3AB7-61C3-40D5-AC33-C26F1D633E00Q33582151-BD7BBBA6-C65C-4702-AA58-ACDE73742E17Q33889586-4FB41E94-7E86-4109-9A1D-51EA0DAB6771Q34250990-6B3FD1F6-F2D7-4C0E-8D94-939A6F0F2FDAQ34853745-5F2CA0AF-A6D2-4F39-B408-EFD599C7C49CQ35581616-5B31FEB6-A6EB-4AD8-99E0-2AE64BC643E2Q35829459-33896992-1D0A-42E4-B03D-CA3FDE5957A5Q36018553-42376DE8-DF1C-44B9-A543-196FDB197AEFQ36844696-14681146-9E50-4FEF-BF5F-9AC281F07BBEQ37403981-8E6D3EFD-64EA-4BDA-87F7-0BD84BBF5D41Q37718775-F2CCB26D-7868-4299-A983-519E0CB56E29Q38612239-3EC81BDE-106E-4116-8EAD-40645FA07DD4Q41364439-FBC9CE23-BC2A-45FB-9CB4-8CF97DB960B0Q42535825-32178591-8E8F-411F-9A8C-783183EEC96EQ42970480-1C725F55-FE1F-4974-872D-E26166DB6612Q43167305-728AE70F-ECE5-47A4-A2D1-A7DCFD205BD1Q43202813-3BE7471D-4F83-4E7A-8C4A-CF7532FADA37Q44909589-D55D6219-11C5-49D5-8BC1-E81DD3F6FEEFQ46437379-9DD90E72-9186-4930-9416-2CB3046C7F1CQ46782277-EFA5A76C-1D3F-4B62-9F79-B8A98E27AC50Q46784655-3B4D7AAC-DC57-4CAC-8AA2-6E1C3199BDE3Q55254641-D6E7CC4B-C06A-4DF4-9ED8-DAB61FBD51CE
P2860
Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Plasma asymmetric dimethylargi ...... tion in hypertensive patients.
@en
Plasma asymmetric dimethylargi ...... tion in hypertensive patients.
@nl
type
label
Plasma asymmetric dimethylargi ...... tion in hypertensive patients.
@en
Plasma asymmetric dimethylargi ...... tion in hypertensive patients.
@nl
prefLabel
Plasma asymmetric dimethylargi ...... tion in hypertensive patients.
@en
Plasma asymmetric dimethylargi ...... tion in hypertensive patients.
@nl
P2093
P1476
Plasma asymmetric dimethylargi ...... tion in hypertensive patients.
@en
P2093
Hideki Fujii
Kei Kamide
Satoshi Nakatani
Shin Takiuchi
Takeshi Horio
Toshio Ogihara
Yuhei Kawano
P304
P356
10.1016/J.AMJHYPER.2004.05.005
P577
2004-09-01T00:00:00Z